266 related articles for article (PubMed ID: 28870383)
1. Advancing Alzheimer's research: A review of big data promises.
Zhang R; Simon G; Yu F
Int J Med Inform; 2017 Oct; 106():48-56. PubMed ID: 28870383
[TBL] [Abstract][Full Text] [Related]
2. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
[TBL] [Abstract][Full Text] [Related]
3. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
6. Domain Transfer Learning for MCI Conversion Prediction.
Cheng B; Liu M; Zhang D; Munsell BC; Shen D
IEEE Trans Biomed Eng; 2015 Jul; 62(7):1805-1817. PubMed ID: 25751861
[TBL] [Abstract][Full Text] [Related]
7. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
[TBL] [Abstract][Full Text] [Related]
8. [Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].
Shoji M
Brain Nerve; 2012 May; 64(5):497-504. PubMed ID: 22570063
[TBL] [Abstract][Full Text] [Related]
9. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
11. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
12. On the early diagnosis of Alzheimer's Disease from multimodal signals: A survey.
Alberdi A; Aztiria A; Basarab A
Artif Intell Med; 2016 Jul; 71():1-29. PubMed ID: 27506128
[TBL] [Abstract][Full Text] [Related]
13. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
Xu L; Wu X; Chen K; Yao L
Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
[TBL] [Abstract][Full Text] [Related]
14. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
15. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
16. Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.
Hochstetler H; Trzepacz PT; Wang S; Yu P; Case M; Henley DB; Degenhardt E; Leoutsakos JM; Lyketsos CG
J Alzheimers Dis; 2016; 50(1):271-82. PubMed ID: 26639960
[TBL] [Abstract][Full Text] [Related]
17. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
[TBL] [Abstract][Full Text] [Related]
18. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
Li Q; Wu X; Xu L; Chen K; Yao L; Li R
Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
[TBL] [Abstract][Full Text] [Related]
19. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
